Loading…
Vikas Lifecare (VIKASLIFE)₹1.180.00%Trading & Distributors
In the Mar 2026 quarter (consolidated), Vikas Lifecare reported sales of ₹169 Cr, up 25.3% from Mar 2025, and net profit of ₹41.89 Cr. For the year to Mar 2026, sales were ₹499 Cr and net profit ₹17.95 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 98.80 | 116 | 98.85 | 132 | 91.82 | 135 | 118 | 135 | 91.87 | 141 | 96.82 | 169 |
| Expenses | 95.92 | 114 | 104 | 128 | 92.04 | 136 | 121 | 158 | 97.94 | 259 | 127 | 195 |
| Operating Profit | 2.99 | 1.99 | −4.99 | 3.99 | 0.00 | −0.99 | −2.99 | −22.95 | −5.98 | −118 | −29.93 | −25.93 |
| OPM % | 2.7% | 2.0% | −4.8% | 2.7% | −0.3% | −1.0% | −2.7% | −16.9% | −6.0% | −82.9% | −30.9% | −16.0% |
| Other Income | 11.99 | 7.01 | 3.01 | −2.01 | 1.99 | 3.01 | −1.01 | 21.01 | 133 | 1.01 | 0.99 | 64.97 |
| Interest | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 2.01 |
| Depreciation | 0.99 | 0.99 | 1.01 | 0.99 | 0.99 | 2.01 | 0.99 | 1.99 | 0.99 | 1.99 | 1.99 | 0.99 |
| Profit before tax | 12.95 | 7.97 | −2.99 | −0.99 | 0.00 | −0.99 | −6.97 | −4.98 | 125 | −120 | −32.90 | 34.88 |
| Tax % | 9.0% | 2.0% | 28.0% | 222.0% | 9,833.0% | −349.0% | 1.0% | −46.0% | 0.0% | −1.0% | −12.0% | −18.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | −5.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 11.97 | 7.99 | −3.99 | −1.99 | −2.99 | 1.99 | −6.98 | −2.99 | 125 | −119 | −28.93 | 41.89 |
| EPS (Rs) | 0.09 | 0.06 | −0.03 | −0.02 | −0.03 | 0.02 | −0.05 | −0.03 | 0.68 | −0.65 | −0.17 | 0.23 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 74.88 | 300 | 475 | 446 | 479 | 499 | 498 |
| Expenses | 66.93 | 302 | 464 | 442 | 488 | 616 | 679 |
| Operating Profit | 7.98 | −0.99 | 11.97 | 3.99 | −7.98 | −116 | −179 |
| OPM % | 10.0% | −0.3% | 2.5% | 0.9% | −1.6% | −23.0% | −36.0% |
| Other Income | −3.01 | 44.03 | −27.98 | 20.01 | 6.01 | 136 | 200 |
| Interest | 5.01 | 2.01 | 2.01 | 3.01 | 5.01 | 7.01 | 7.04 |
| Depreciation | 0.99 | 2.01 | 2.99 | 3.99 | 6.99 | 5.99 | 5.96 |
| Profit before tax | −1.99 | 38.84 | −20.94 | 16.94 | −12.95 | 6.98 | 6.94 |
| Tax % | 133.0% | 26.0% | −27.0% | 21.0% | −15.0% | −157.0% | — |
| Exceptional items | −6.01 | 7.01 | 0.00 | 2.01 | −7.01 | 0.00 | 0.00 |
| Net Profit | −3.99 | 28.95 | −15.97 | 12.98 | −10.98 | 17.95 | 18.96 |
| EPS (Rs) | −0.04 | 0.27 | −0.12 | 0.10 | −0.07 | 0.11 | 0.09 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 66.01 | 110 | 144 | 165 | 186 | 186 |
| Reserves | 0.00 | 90.30 | 187 | 311 | 346 | 366 |
| Borrowings | 42.03 | 23.03 | 30.01 | 33.98 | 76.94 | 105 |
| Other Liabilities | 40.80 | 97.53 | 92.55 | 43.79 | 120 | 103 |
| Total Liabilities | 149 | 321 | 454 | 555 | 728 | 760 |
| Fixed Assets | 11.97 | 27.93 | 46.87 | 55.88 | 60.84 | 35.88 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 |
| Investments | 3.01 | 84.03 | 77.04 | 183 | 54.09 | 394 |
| Other Assets | 133 | 208 | 330 | 316 | 613 | 330 |
| Inventories | 26.93 | 27.93 | 12.98 | 8.97 | 4.99 | 4.99 |
| Trade receivables | 70.77 | 42.85 | 168 | 145 | 127 | 140 |
| Cash & equivalents | 0.00 | 7.99 | 9.99 | 13.99 | 5.99 | 0.99 |
| Total Assets | 149 | 321 | 454 | 555 | 728 | 760 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | −7.98 | −14.96 | −112 | −41.91 | −221 | 309 |
| Cash from investing activity | 11.97 | −36.90 | −35.89 | −90.81 | 106 | −333 |
| Cash from financing activity | −3.99 | 58.79 | 150 | 137 | 108 | 19.92 |
| Net cash flow | 0.00 | 7.98 | 1.99 | 3.99 | −7.98 | −4.99 |
| Capex | 1.01 | 13.01 | 17.99 | 16.01 | 12.99 | 2.01 |
| Free cash flow | −9.03 | −28.10 | −131 | −51.15 | −235 | 318 |
| CFO / OP % | −90.0% | 1,565.0% | −949.0% | −1,045.0% | 2,905.0% | −270.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 347 | 52 | 130 | 120 | 97 | 103 |
| Inventory days | 156 | 36 | 10 | 8 | 4 | 4 |
| Days payable | 216 | 84 | 48 | 13 | 47 | 44 |
| Cash conversion cycle | 288 | 5 | 93 | 116 | 55 | 63 |
| Working capital days | 270 | 12 | 85 | 141 | 85 | 74 |
| ROCE % | — | 19.0% | −7.0% | 4.0% | 0.0% | 2.0% |
For the Mar 2026 quarter, Vikas Lifecare reported sales of ₹169 Cr, up 25.3% year on year and net profit of ₹41.89 Cr. The operating margin was −16.0%.
Vikas Lifecare's sales for the year to Mar 2026 were ₹499 Cr; over the last twelve months they were ₹498 Cr.
Net profit for the year to Mar 2026 was ₹17.95 Cr, and ₹18.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.09.
Vikas Lifecare reported borrowings of ₹105 Cr at Mar 2026, against cash and equivalents of ₹0.99 Cr.
Cash from operations was ₹309 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹318 Cr.